Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Kaiyue Life Science and Technology is a biotechnology company based in Shenzhen, China, dedicated to the development of mRNA-based vaccines and therapeutics. The company utilizes a proprietary mRNA platform and advanced lipid nanoparticle (LNP) delivery technology to target infectious diseases and various cancers. Their research and development efforts are focused on optimizing mRNA stability and translation efficiency to create more effective and safer medical solutions. Kaiyue is currently advancing several candidates through the pre-clinical pipeline, including a next-generation COVID-19 vaccine and personalized tumor vaccines. The leadership team comprises industry veterans with extensive experience in molecular biology and pharmaceutical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Kaiyue Life Science and Technology.